Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone

Leuk Lymphoma. 2017 Mar;58(3):749-751. doi: 10.1080/10428194.2016.1213833. Epub 2016 Aug 11.

Authors

Emmanuelle Verger^{1

2}, Ekarat Rattarittamrong³, Gil Letort², Emmanuel Raffoux⁴, Bruno Cassinat^{1

2}, Jean-Jacques Kiladjian⁵

Affiliations

¹ a Laboratoire de Biologie Cellulaire , AP-HP, Hopital Saint-Louis , Paris , France.
² b Inserm UMRS_1131 , Institut Universitaire d'Hématologie, Hopital Saint-Louis , Paris , France.
³ c Department of Internal Medicine, Faculty of Medicine , Chiang Mai University , Thailand.
⁴ d Service d'Hematologie Adulte , Hopital Saint-Louis , Paris , France.
⁵ e Centre d'Investigations Cliniques , Hopital Saint-Louis , Paris , France.

PMID: 27562925
DOI: 10.1080/10428194.2016.1213833

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers
Cell Transformation, Neoplastic / genetics
Female
Humans
Janus Kinase 2 / genetics
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / etiology*
Middle Aged
Mutation
Primary Myelofibrosis / complications*
Primary Myelofibrosis / genetics
Remission Induction

Substances

Biomarkers
Janus Kinase 2